Literature DB >> 14569275

The promoter -194 C polymorphism of the nicotinic alpha 7 receptor gene has a protective effect against the P50 sensory gating deficit.

E Houy1, G Raux, F Thibaut, A Belmont, C Demily, G Allio, S Haouzir, G Fouldrin, M Petit, T Frebourg, D Campion.   

Abstract

As suggested by several studies, abnormal sensory gating measured by the P50 paradigm could be an endophenotype predisposing to schizophrenia. In a previous work, we have shown a significant association between the presence of at least one -2 bp deletion located within exon 6 of the CHRNA7-like gene and the P50 abnormality in the general population. A recent study involved polymorphisms located in the core promoter region of the CHRNA7 gene as risk factors for the P50 inhibitory deficit. Screening for promoter variants in a large population of schizophrenic patients (n=111) and control subjects (85), for whom auditory-evoked potentials had been recorded did not allow us to replicate these results. By contrast, we showed a significant association between the -194 C allele and a T/C ratio <0.45, thus demonstrating a protective effect of this variant for the sensory gating deficit. Such conflicting results can be reconciled if we consider that the -194 C polymorphism has no causative effect, but is in linkage disequilibrium with other causal variations for the P50 sensory gating deficit, and that different alleles are in disequilibrium in different populations.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14569275     DOI: 10.1038/sj.mp.4001443

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  22 in total

1.  Transcriptional repression of the α7 nicotinic acetylcholine receptor subunit gene (CHRNA7) by activating protein-2α (AP-2α).

Authors:  Jessica Finlay-Schultz; Andrew Canastar; Margaret Short; Mohamed El Gazzar; Christina Coughlan; Sherry Leonard
Journal:  J Biol Chem       Date:  2011-10-06       Impact factor: 5.157

2.  Inhibition of the P50 cerebral evoked response to repeated auditory stimuli: results from the Consortium on Genetics of Schizophrenia.

Authors:  Ann Olincy; David L Braff; Lawrence E Adler; Kristin S Cadenhead; Monica E Calkins; Dorcas J Dobie; Michael F Green; Tiffany A Greenwood; Raquel E Gur; Reuben C Gur; Gregory A Light; James Mintz; Keith H Nuechterlein; Allen D Radant; Nicholas J Schork; Larry J Seidman; Larry J Siever; Jeremy M Silverman; William S Stone; Neal R Swerdlow; Debby W Tsuang; Ming T Tsuang; Bruce I Turetsky; Brandie D Wagner; Robert Freedman
Journal:  Schizophr Res       Date:  2010-04-10       Impact factor: 4.939

Review 3.  Nicotinic mechanisms in the treatment of psychotic disorders: a focus on the α7 nicotinic receptor.

Authors:  Ann Olincy; Robert Freedman
Journal:  Handb Exp Pharmacol       Date:  2012

4.  Sensory gating and alpha-7 nicotinic receptor gene allelic variants in schizoaffective disorder, bipolar type.

Authors:  Laura F Martin; Sherry Leonard; Mei-Hua Hall; Jason R Tregellas; Robert Freedman; Ann Olincy
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2007-07-05       Impact factor: 3.568

Review 5.  Treating schizophrenia symptoms with an alpha7 nicotinic agonist, from mice to men.

Authors:  Ann Olincy; Karen E Stevens
Journal:  Biochem Pharmacol       Date:  2007-07-17       Impact factor: 5.858

6.  P50 inhibitory sensory gating in schizophrenia: analysis of recent studies.

Authors:  Robert Freedman; Amanda M Olsen-Dufour; Ann Olincy
Journal:  Schizophr Res       Date:  2020-02-13       Impact factor: 4.939

7.  Genetic Association Study of the Alpha 7 Nicotinic Receptor (CHRNA7) with the Development of Schizophrenia and Bipolar Disorder in Korean Population.

Authors:  Eun-Jeong Joo; Kyu Young Lee; Hyun Sook Kim; Se Hyun Kim; Yong Min Ahn; Yong Sik Kim
Journal:  Psychiatry Investig       Date:  2010-07-12       Impact factor: 2.505

Review 8.  The endophenotype concept in psychiatric genetics.

Authors:  Jonathan Flint; Marcus R Munafò
Journal:  Psychol Med       Date:  2006-09-18       Impact factor: 7.723

9.  Perinatal choline effects on neonatal pathophysiology related to later schizophrenia risk.

Authors:  Randal G Ross; Sharon K Hunter; Lizbeth McCarthy; Julie Beuler; Amanda K Hutchison; Brandie D Wagner; Sherry Leonard; Karen E Stevens; Robert Freedman
Journal:  Am J Psychiatry       Date:  2013-03       Impact factor: 18.112

Review 10.  Research review: Cholinergic mechanisms, early brain development, and risk for schizophrenia.

Authors:  Randal G Ross; Karen E Stevens; William R Proctor; Sherry Leonard; Michael A Kisley; Sharon K Hunter; Robert Freedman; Catherine E Adams
Journal:  J Child Psychol Psychiatry       Date:  2009-11-18       Impact factor: 8.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.